These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24607201)

  • 1. A thermodynamic based approach on the investigation of a diflunisal pharmaceutical co-crystal with improved intrinsic dissolution rate.
    Evora AO; Castro RA; Maria TM; Silva MR; Ter Horst JH; Canotilho J; Eusébio ME
    Int J Pharm; 2014 May; 466(1-2):68-75. PubMed ID: 24607201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of 1:1 Carbamazepine:Nicotinamide cocrystals by spray drying.
    Patil SP; Modi SR; Bansal AK
    Eur J Pharm Sci; 2014 Oct; 62():251-7. PubMed ID: 24931188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals.
    Soares FL; Carneiro RL
    J Pharm Biomed Anal; 2014 Feb; 89():166-75. PubMed ID: 24291798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical cocrystals of diflunisal and diclofenac with theophylline.
    Surov AO; Voronin AP; Manin AN; Manin NG; Kuzmina LG; Churakov AV; Perlovich GL
    Mol Pharm; 2014 Oct; 11(10):3707-15. PubMed ID: 25184906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine: Design and synthesis of new multicomponent solid forms.
    Évora AOL; Castro RAE; Maria TMR; Ramos Silva M; Canotilho J; Eusébio MES
    Eur J Pharm Sci; 2019 Mar; 129():148-162. PubMed ID: 30639400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the Solubility of Pharmaceutical Cocrystals in Solvent/Anti-Solvent Mixtures.
    Lange L; Heisel S; Sadowski G
    Molecules; 2016 May; 21(5):. PubMed ID: 27164075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.
    Martínez-Ohárriz MC; Martín C; Goñi MM; Rodríguez-Espinosa C; Tros de Ilarduya-Apaolaza MC; Sánchez M
    J Pharm Sci; 1994 Feb; 83(2):174-7. PubMed ID: 8169784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethyl-paraben and nicotinamide mixtures: apparent solubility, thermal behavior and X-ray structure of the 1:1 co-crystal.
    Nicoli S; Bilzi S; Santi P; Caira MR; Li J; Bettini R
    J Pharm Sci; 2008 Nov; 97(11):4830-9. PubMed ID: 18314888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive spectroscopic study of the polymorphs of diflunisal and their phase transformations.
    Pallipurath AR; Civati F; Sibik J; Crowley C; Zeitler JA; McArdle P; Erxleben A
    Int J Pharm; 2017 Aug; 528(1-2):312-321. PubMed ID: 28603011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of polyethylene glycol 4000 on the polymorphic forms of diflunisal.
    Martínez-Ohárriz MC; Martín C; Goñi MM; Rodríguez-Espinosa C; Tros-Ilarduya MC; Zornoza A
    Eur J Pharm Sci; 1999 May; 8(2):127-32. PubMed ID: 10210735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization, and molecular modeling of a pharmaceutical co-crystal: (2-chloro-4-nitrobenzoic acid):(nicotinamide).
    Lemmerer A; Esterhuysen C; Bernstein J
    J Pharm Sci; 2010 Sep; 99(9):4054-71. PubMed ID: 20574994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuning solubility and stability of hydrochlorothiazide co-crystals.
    Sanphui P; Rajput L
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2014 Feb; 70(Pt 1):81-90. PubMed ID: 24441131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
    Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
    Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide.
    Chow SF; Chen M; Shi L; Chow AH; Sun CC
    Pharm Res; 2012 Jul; 29(7):1854-65. PubMed ID: 22359146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theophylline-nicotinamide cocrystal formation in physical mixture during storage.
    Ervasti T; Aaltonen J; Ketolainen J
    Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility, metastable zone width measurement and crystal growth of the 1:1 benzoic acid/isonicotinamide cocrystal in solutions of variable stoichiometry.
    Boyd S; Back K; Chadwick K; Davey RJ; Seaton CC
    J Pharm Sci; 2010 Sep; 99(9):3779-86. PubMed ID: 20665843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: Screening, crystal structures, thermochemical and solubility studies.
    Drozd KV; Manin AN; Churakov AV; Perlovich GL
    Eur J Pharm Sci; 2017 Mar; 99():228-239. PubMed ID: 28011126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, and evaluation of celecoxib eutectic mixtures with adipic acid/saccharin for improvement of wettability and dissolution rate.
    Hyun SM; Lee BJ; Abuzar SM; Lee S; Joo Y; Hong SH; Kang H; Kwon KA; Velaga S; Hwang SJ
    Int J Pharm; 2019 Jan; 554():61-71. PubMed ID: 30347274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid phase drug-drug pharmaceutical co-crystal formed between pyrazinamide and diflunisal: Structural characterization based on terahertz/Raman spectroscopy combining with DFT calculation.
    Wu X; Wang Y; Xue J; Liu J; Qin J; Hong Z; Du Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jun; 234():118265. PubMed ID: 32203686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of tableting properties and dissolution rate of naproxen co-grinded with nicotinamide: preparation and characterization of co-grinded mixture.
    Khizar N; Abbas N; Ahmed M; Ahmad M; Mustafa Z; Jehangir M; Mohammed Al-Ahmary K; Hussain A; Bukhari NI; Ali I
    Drug Dev Ind Pharm; 2024 Jun; 50(6):537-549. PubMed ID: 38771120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.